𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinoma

✍ Scribed by Frederik A. Verburg; Markus Dietlein; Michael Lassmann; Markus Luster; Christoph Reiners

Publisher
Springer
Year
2008
Tongue
English
Weight
98 KB
Volume
36
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Postsurgical thyroid remnant estimation
Postsurgical thyroid remnant estimation by 99mTc-pertechnetate scintigraphy predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma
✍ Luca Giovanella; Sergio Suriano; Riccardo Ricci; Luca Ceriani; Frederik Anton Ve πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 93 KB

## Abstract ## __Background.__ The purpose of this study was to evaluate the relationship between postsurgical neck ^99m^technetium (^99m^Tc)‐pertechnetate uptake and the rate of successful remnant ablation after radioiodine treatment in patients with differentiated thyroid carcinoma (DTC). ## __

Prospective randomized clinical trial to
Prospective randomized clinical trial to evaluate the optimal dose of 131I for remnant ablation in patients with differentiated thyroid carcinoma
✍ Adam Taube; GΓΆran Lundell πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 100 KB πŸ‘ 2 views

outcome of 87 patients with gallbladder carcinoma (GBC) who underwent surgery. The authors concluded that surgical resection provides significantly better survival than a bypass procedure or exploratory laparotomy alone. Because radical tumor resection may significantly improve survival as compared

Prospective randomized clinical trial to
Prospective randomized clinical trial to evaluate the optimal dose of 131I for remnant ablation in patients with differentiated thyroid carcinoma
✍ Chandrasekhar Bal; Ajit K. Padhy; Suman Jana; Gauri S. Pant; Amar K. Basu πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 672 KB

## BACKGROUND. Radioiodine has been used for more than a half-century to ablate thyroid remnants following thyroid surgery, but a single optimal dose has not been established. We designed a prospective randomized trial to determine the optimal dose of 13'1 for remnant ablation. METHODS. Using a si